Reported Earnings • Apr 29
Full year 2025 earnings released: CN¥2.94 loss per share (vs CN¥0.082 profit in FY 2024) Full year 2025 results: CN¥2.94 loss per share (down from CN¥0.082 profit in FY 2024). Revenue: CN¥527.7m (down 17% from FY 2024). Net loss: CN¥474.0m (down CN¥487.2m from profit in FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance. Announcement • Apr 28
Hunan Copote Science Technology Co.,Ltd., Annual General Meeting, May 21, 2026 Hunan Copote Science Technology Co.,Ltd., Annual General Meeting, May 21, 2026, at 13:30 China Standard Time. Location: No. 2, Yulan Road, Yuelu District, Changsha, Hunan China Announcement • Mar 30
Hunan Copote Science Technology Co.,Ltd. to Report Q1, 2026 Results on Apr 28, 2026 Hunan Copote Science Technology Co.,Ltd. announced that they will report Q1, 2026 results on Apr 28, 2026 Announcement • Dec 26
Hunan Copote Science Technology Co.,Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026 Hunan Copote Science Technology Co.,Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026 Reported Earnings • Oct 31
Third quarter 2025 earnings released: CN¥0.16 loss per share (vs CN¥0.004 profit in 3Q 2024) Third quarter 2025 results: CN¥0.16 loss per share (down from CN¥0.004 profit in 3Q 2024). Revenue: CN¥88.1m (up 2.2% from 3Q 2024). Net loss: CN¥24.5m (down CN¥25.1m from profit in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 81% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Announcement • Sep 30
Hunan Copote Science Technology Co.,Ltd. to Report Q3, 2025 Results on Oct 31, 2025 Hunan Copote Science Technology Co.,Ltd. announced that they will report Q3, 2025 results on Oct 31, 2025 Board Change • Aug 21
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. Independent Director Dingjian Wang was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. New Risk • Jul 11
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.0x net interest cover). Minor Risks Share price has been volatile over the past 3 months (6.8% average weekly change). Large one-off items impacting financial results. Announcement • Jun 30
Hunan Copote Science Technology Co.,Ltd. to Report First Half, 2025 Results on Aug 30, 2025 Hunan Copote Science Technology Co.,Ltd. announced that they will report first half, 2025 results on Aug 30, 2025 Announcement • Apr 29
Hunan Copote Science Technology Co.,Ltd., Annual General Meeting, May 22, 2025 Hunan Copote Science Technology Co.,Ltd., Annual General Meeting, May 22, 2025, at 13:30 China Standard Time. Announcement • Mar 28
Hunan Copote Science Technology Co.,Ltd. to Report Q1, 2025 Results on Apr 29, 2025 Hunan Copote Science Technology Co.,Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025 New Risk • Feb 21
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (37% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (8.3% average weekly change). New Risk • Jan 12
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. This is currently the only risk that has been identified for the company. Announcement • Dec 27
Hunan Copote Science Technology Co.,Ltd. to Report Fiscal Year 2024 Results on Apr 29, 2025 Hunan Copote Science Technology Co.,Ltd. announced that they will report fiscal year 2024 results on Apr 29, 2025 Reported Earnings • Oct 29
Third quarter 2024 earnings released: EPS: CN¥0.004 (vs CN¥0.042 loss in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.004 (up from CN¥0.042 loss in 3Q 2023). Revenue: CN¥86.2m (down 21% from 3Q 2023). Net income: CN¥640.0k (up CN¥7.48m from 3Q 2023). Profit margin: 0.7% (up from net loss in 3Q 2023). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth. Announcement • Sep 30
Hunan Copote Science Technology Co.,Ltd. to Report Q3, 2024 Results on Oct 26, 2024 Hunan Copote Science Technology Co.,Ltd. announced that they will report Q3, 2024 results on Oct 26, 2024 Reported Earnings • Aug 31
Second quarter 2024 earnings released: CN¥0.041 loss per share (vs CN¥0.087 loss in 2Q 2023) Second quarter 2024 results: CN¥0.041 loss per share (improved from CN¥0.087 loss in 2Q 2023). Revenue: CN¥126.7m (up 3.8% from 2Q 2023). Net loss: CN¥6.95m (loss narrowed 50% from 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings. Announcement • Jun 28
Hunan Copote Science Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 31, 2024 Hunan Copote Science Technology Co.,Ltd. announced that they will report first half, 2024 results on Aug 31, 2024 Announcement • Apr 29
Hunan Copote Science Technology Co.,Ltd., Annual General Meeting, May 17, 2024 Hunan Copote Science Technology Co.,Ltd., Annual General Meeting, May 17, 2024, at 14:00 China Standard Time. Location: No. 8, Dongtiejiangyingshun Yitiao, Fengtai District, Beijing China Reported Earnings • Apr 01
Full year 2023 earnings released: EPS: CN¥0.033 (vs CN¥0.24 loss in FY 2022) Full year 2023 results: EPS: CN¥0.033 (up from CN¥0.24 loss in FY 2022). Revenue: CN¥585.5m (flat on FY 2022). Net income: CN¥5.29m (up CN¥44.7m from FY 2022). Profit margin: 0.9% (up from net loss in FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 94 percentage points per year, which is a significant difference in performance. Announcement • Mar 29
Hunan Copote Science Technology Co.,Ltd. to Report Q1, 2024 Results on Apr 27, 2024 Hunan Copote Science Technology Co.,Ltd. announced that they will report Q1, 2024 results on Apr 27, 2024 Announcement • Dec 29
Hunan Copote Science Technology Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 30, 2024 Hunan Copote Science Technology Co.,Ltd. announced that they will report fiscal year 2023 results on Mar 30, 2024 New Risk • Dec 05
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 8.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.0% average weekly change). Earnings have declined by 5.2% per year over the past 5 years. Reported Earnings • Nov 01
Third quarter 2023 earnings released: CN¥0.042 loss per share (vs CN¥0.079 loss in 3Q 2022) Third quarter 2023 results: CN¥0.042 loss per share (improved from CN¥0.079 loss in 3Q 2022). Revenue: CN¥108.9m (down 43% from 3Q 2022). Net loss: CN¥6.84m (loss narrowed 47% from 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has increased by 12% per year, which means it is well ahead of earnings. New Risk • Oct 18
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 7.2% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (6.6% average weekly change). Announcement • Sep 30
Hunan Copote Science Technology Co.,Ltd. to Report Q3, 2023 Results on Oct 28, 2023 Hunan Copote Science Technology Co.,Ltd. announced that they will report Q3, 2023 results at 3:00 PM, China Standard Time on Oct 28, 2023 Reported Earnings • Aug 29
Second quarter 2023 earnings released: CN¥0.087 loss per share (vs CN¥0.021 loss in 2Q 2022) Second quarter 2023 results: CN¥0.087 loss per share (further deteriorated from CN¥0.021 loss in 2Q 2022). Revenue: CN¥122.1m (down 14% from 2Q 2022). Net loss: CN¥14.0m (loss widened 311% from 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings. Announcement • Jun 28
Hunan Copote Science Technology Co.,Ltd. to Report First Half, 2023 Results on Aug 29, 2023 Hunan Copote Science Technology Co.,Ltd. announced that they will report first half, 2023 results on Aug 29, 2023 Reported Earnings • May 02
First quarter 2023 earnings released: CN¥0.015 loss per share (vs CN¥0.088 loss in 1Q 2022) First quarter 2023 results: CN¥0.015 loss per share (improved from CN¥0.088 loss in 1Q 2022). Revenue: CN¥97.3m (up 31% from 1Q 2022). Net loss: CN¥2.40m (loss narrowed 83% from 1Q 2022). Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth. Reported Earnings • Oct 29
Third quarter 2022 earnings released: CN¥0.079 loss per share (vs CN¥0.063 loss in 3Q 2021) Third quarter 2022 results: CN¥0.079 loss per share (further deteriorated from CN¥0.063 loss in 3Q 2021). Revenue: CN¥190.1m (up 177% from 3Q 2021). Net loss: CN¥12.8m (loss widened 27% from 3Q 2021). Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 31
Second quarter 2022 earnings released: CN¥0.021 loss per share (vs CN¥0.001 profit in 2Q 2021) Second quarter 2022 results: CN¥0.021 loss per share (down from CN¥0.001 profit in 2Q 2021). Revenue: CN¥142.4m (up 42% from 2Q 2021). Net loss: CN¥3.41m (down CN¥3.50m from profit in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings. Reported Earnings • Apr 30
First quarter 2022 earnings released: CN¥0.088 loss per share (vs CN¥0.026 loss in 1Q 2021) First quarter 2022 results: CN¥0.088 loss per share (down from CN¥0.026 loss in 1Q 2021). Revenue: CN¥74.3m (up 18% from 1Q 2021). Net loss: CN¥14.2m (loss widened 245% from 1Q 2021). Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 09
Second quarter 2021 earnings released: EPS CN¥0.001 (vs CN¥0.029 in 2Q 2020) The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: CN¥100.3m (up 20% from 2Q 2020). Net income: CN¥90.2k (down 98% from 2Q 2020). Profit margin: 0.1% (down from 5.6% in 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 15% per year whereas the company’s share price has fallen by 16% per year. Reported Earnings • Apr 28
First quarter 2021 earnings released: CN¥0.026 loss per share (vs CN¥0.088 loss in 1Q 2020) The company reported a solid first quarter result with reduced losses, improved revenues and improved control over expenses. First quarter 2021 results: Revenue: CN¥63.2m (up 207% from 1Q 2020). Net loss: CN¥4.13m (loss narrowed 71% from 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Feb 03
New 90-day low: CN¥8.90 The company is down 23% from its price of CN¥11.63 on 05 November 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the IT industry, which is down 25% over the same period. Is New 90 Day High Low • Jan 07
New 90-day low: CN¥9.73 The company is down 23% from its price of CN¥12.63 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the IT industry, which is down 21% over the same period. Is New 90 Day High Low • Dec 16
New 90-day low: CN¥11.47 The company is down 10.0% from its price of CN¥12.77 on 17 September 2020. The Chinese market is up 3.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the IT industry, which is down 18% over the same period. Reported Earnings • Oct 28
Third quarter earnings released Over the last 12 months the company has reported total losses of CN¥46.5m, with losses widening by 292% from the prior year. Total revenue was CN¥215.3m over the last 12 months, down 41% from the prior year. Is New 90 Day High Low • Oct 27
New 90-day low: CN¥12.26 The company is down 14% from its price of CN¥14.19 on 29 July 2020. The Chinese market is flat over the last 90 days, indicating the company underperformed over that time. It also underperformed the IT industry, which is down 3.0% over the same period. Announcement • Oct 20
Hunan Copote Science Technology Co.,Ltd. to Report Q3, 2020 Results on Oct 27, 2020 Hunan Copote Science Technology Co.,Ltd. announced that they will report Q3, 2020 results on Oct 27, 2020 Announcement • Jul 09
Hunan Copote Science Technology Co.,Ltd. to Report First Half, 2020 Results on Aug 25, 2020 Hunan Copote Science Technology Co.,Ltd. announced that they will report first half, 2020 results on Aug 25, 2020